Author: Baig, Mohammad H.; Ahmad, Khurshid; Rabbani, Gulam; Choi, Inho
Title: Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition Cord-id: x17pqlvt Document date: 2018_2_7
ID: x17pqlvt
Snippet: Alzheimer’s disease (AD) is a form of dementia and the most common progressive neurodegenerative disease (ND). The targeting of amyloid-beta (Aβ) aggregation is one of the most widely used strategies to manage AD, and efforts are being made globally to develop peptide-based compounds for the early diagnosis and treatment of AD. Here, we briefly discuss the use of peptide-based compounds for the early diagnosis and treatment of AD and the use of peptide-based inhibitors targeting various Aβ a
Document: Alzheimer’s disease (AD) is a form of dementia and the most common progressive neurodegenerative disease (ND). The targeting of amyloid-beta (Aβ) aggregation is one of the most widely used strategies to manage AD, and efforts are being made globally to develop peptide-based compounds for the early diagnosis and treatment of AD. Here, we briefly discuss the use of peptide-based compounds for the early diagnosis and treatment of AD and the use of peptide-based inhibitors targeting various Aβ aggregation checkpoints. In addition, we briefly discuss recent applications of peptide-based inhibitors against various AD targets including amyloid beta, β-site amyloid precursor protein cleaving enzyme 1 (BACE1), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), tyrosine phosphatase (TP) and potassium channel KV1.3.
Search related documents:
Co phrase search for related documents- acid residue and active site: 1, 2, 3, 4, 5, 6, 7, 8, 9
- active site and ad disease: 1
- activity function and ad disease: 1, 2, 3
- activity function structure and ad disease: 1
- ad characteristic and ad disease: 1
- ad detection and ad early detection: 1, 2, 3
- ad disease and ad early detection: 1, 2, 3
- ad disease and ad inhibitor: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date